by the global periodontal therapeutics market for the historical period 2017–2018 and forecast period 2019–2027, rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health are projected to drive the global periodontal therapeutics market
According to the report, the global periodontal therapeutics market was valued at US$ 536.8 Mn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2030
Get the sample copy of report@ https://qyresearchmedical.com/sample/111890
Rise in Global Burden of Periodontal Diseases: A Key Driver
Periodontal diseases comprising gingivitis and periodontitis are prevalent both in developing and developed countries and affect around 20% to 50% of the global population
According to the Global Burden of Disease Study (GBD, 1990–2010), severe periodontitis is the 6th most prevalent disease worldwide, and has an overall prevalence of 11.2% and an estimated 743 million people worldwide are affected by it. The global burden of periodontal diseases has increased by as much as 57.3% from 1990 to 2010.
Periodontitis is one of the major causes of tooth loss in adult population across the world. These individuals are at risk of edentulism, masticatory dysfunction, and multiple tooth loss which in turn affects nutrition, self-esteem, and quality of life as well as imposes high health care and significant socio-economic costs.
The global cost of lost productivity due to severe periodontitis is estimated to be around US$ 54 Bn per year, while the total economic impact of periodontal diseases accounts for a major component of the US$ 442 Bn direct and indirect cost caused due to oral diseases.
Surge in Awareness About Oral Health to Augment Global Market
Oral health programs work for formulation of national and community policies on effective control of diet and nutrition risk factors for oral diseases such as periodontal disease, dental disease, etc.
Periodontal diseases have a significant socio-economic impact on populations and governments across the world; however, treatment to these diseases still remains unavailable in developing countries due to low priority accorded to these diseases
The Global Periodontal Health Project (GPHP) was launched in October 2015 in order to reduce the overall global burden of periodontal diseases. The project aims to decrease the burden associated with these diseases by raising awareness of its impact and engaging oral health and other health professionals, policymakers, educators, and the general public in promoting periodontal health.
The Global Periodontal Health Project aims to make periodontal health a priority issue at the national level by engaging with Ministers of Health, Chief Dental Officers and the local populations, and also increase the disease awareness levels by actively disseminating dental educational promotional tools.
Uninsured Dental Care in Several Developed and Developing Countries to Hamper Global Periodontal Therapeutics Market
Advanced dental and periodontal procedures turn out to be too expensive for an average citizen in both developed and developing countries
Oral health care coverage is seen to be low in low- and middle-income countries. Dental care is not insured in several developed countries such as Canada and the U.S. In the U.S., only the most rudimentary dental care is covered by health insurance plan. According to the National Association of Dental Plans, over 114 million people in the U.S. were known to be without dental coverage in 2014.
North America to Account for Major Share of Global Periodontal Therapeutics Market
North America is projected to account for leading share of the global periodontal therapeutics market due to rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, surge in research & developmental activities in periodontal therapeutics, and presence of key players
The periodontal therapeutics market in Asia Pacific is projected to grow at a rapid pace during the forecast period due to increase in geriatric population, rise in research & developmental activities, surge in initiatives by governments in the health care sector, and rise in interest of key players in expanding presence in the region
Global Periodontal Therapeutics Market: Competitive Landscape
This report profiles major players in the global periodontal therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
Key players operating in the global periodontal therapeutics market include
- Den-Mat Holdings, LLC
- Valeant Pharmaceuticals International, Inc.
- Dexcel Pharma
- 3M Company
- Oral Science
- Kaken Pharmaceutical Co., Ltd.
Key Questions Answered in Global Periodontal Therapeutics Market Report
- What is the scope of growth of product companies in the global periodontal therapeutics market?
- What will be the Y-o-Y growth of the global periodontal therapeutics market between 2019 and 2027?
- What is the influence of pipeline Systemic Antibiotics on the global periodontal therapeutics market?
- Will North America continue to be the most profitable market for providers of periodontal therapeutics treatment products?
- Which factors will hamper the growth of the global periodontal therapeutics market during the forecast period?
- Which are the leading companies in the global periodontal therapeutics market?
Global Periodontal Therapeutics Market – Segmentation
Product
- Systemic Antibiotics
- Doxycycline
- Minocycline
- Metronidazole
- Others
- Local Antibiotics
- Arestin
- Periochip
- Atridox
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- E-Commerce
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111890/2900
